Skip to main content
UniHealth

Doctor search

Deepu Madduri, MD

Hematology/Oncology · Stanford

NPI 1740418318

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
16
2 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Plans that list them

16 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Madduri’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

16 of 16 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A107001 · Current

Licensed to practise in California · since 2009 · expires 2026-12-31 · University of Oklahoma College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Money from drug and device companies

$47 in 2025

Industry payments by year
202511None$47
202423None$1,981
202323None$163
202211None$103
2021610$33,024$33,024
20201050$121,780$126,258
2019896$176,120$186,366

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Janssen Global ServicesDarzalex$47
1 payment
  • Meals for Darzalex · 2025-09-17 · $47
See the published payment
Every published payment
Janssen Global ServicesMeals · 2025-09-17Darzalex$47
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $1,981

Payments by company in 2024
E.R. Squibb & Sons L.L.C.None$1,955
2 payments
  • Meals · 2024-06-10 · $950
  • Travel · 2024-06-10 · $1,005
Legend Biotech USANone$26
1 payment
  • Travel · 2024-06-10 · $26

2023: $163

Payments by company in 2023
GenzymeNone$84
1 payment
  • Grant · 2023-06-06 · $84
Legend Biotech USANone$79
2 payments
  • Travel · 2023-06-08 · $47
  • Meals · 2023-06-08 · $32

2022: $103

Payments by company in 2022
GenzymeNone$103
1 payment
  • Grant · 2022-06-09 · $103

2021: $33,024

Payments by company in 2021
Foundation MedicineFoundationone Cdx$24,449
1 payment
  • Consulting for Foundationone Cdx · 2021-05-17 · $24,449
Janssen BiotechNone$2,525
2 payments
  • Consulting · 2021-01-15 · $1,263
  • Consulting · 2021-01-08 · $1,263
CelgeneNone$2,063
1 payment
  • Consulting · 2021-02-16 · $2,063
GlaxoSmithKlineBlenrep$1,950
1 payment
  • Consulting for Blenrep · 2021-03-23 · $1,950
Janssen Research & DevelopmentNone$1,240
1 payment
  • Consulting · 2021-03-31 · $1,240
Janssen Global ServicesNone$797
4 payments
  • Consulting · 2021-04-03 · $50
  • Consulting · 2021-03-17 · $410
  • Consulting · 2021-03-06 · $121
  • Consulting · 2021-02-06 · $216

2020: $126,258

Payments by company in 2020
Foundation MedicineFoundationone Liquid$78,335
10 payments
  • Consulting for Foundationone Cdx · 2020-10-14 · $8,814
  • Consulting for Foundationone Cdx · 2020-10-14 · $4,969
  • Consulting for Foundationone Cdx · 2020-10-14 · $8,657
  • Consulting for Foundationone Cdx · 2020-10-14 · $9,357
  • Consulting for Foundationone Cdx · 2020-10-14 · $7,306
  • Consulting for Foundationone Liquid · 2020-06-10 · $7,963
  • Consulting for Foundationone Liquid · 2020-06-10 · $13,333
  • Consulting for Foundationone Liquid · 2020-03-20 · $6,757
  • Consulting for Foundationone Liquid · 2020-03-20 · $5,000
  • Consulting for Foundationone Liquid · 2020-03-20 · $6,180
Janssen Global ServicesImbruvica$15,990
14 payments
  • Consulting · 2020-12-07 · $1,400
  • Consulting · 2020-12-04 · $2,450
  • Consulting · 2020-11-09 · $7,000
  • Consulting for Imbruvica · 2020-10-16 · $505
  • Consulting · 2020-06-12 · $1,010
  • Consulting · 2020-05-01 · $350
  • Travel · 2020-02-23 · $132
  • Travel · 2020-02-23 · $127
  • Meals · 2020-02-23 · $3
  • Travel · 2020-02-23 · $775
  • Travel · 2020-02-23 · $995
  • Travel · 2020-02-23 · $528
  • Consulting · 2020-02-14 · $700
  • Meals for Pipeline · 2020-01-30 · $14
GlaxoSmithKlineBlenrep$9,100
6 payments
  • Consulting for Blenrep · 2020-12-14 · $1,300
  • Consulting for Blenrep · 2020-11-16 · $2,600
  • Consulting for Blenrep · 2020-09-25 · $325
  • Consulting · 2020-09-04 · $1,950
  • Consulting · 2020-07-10 · $1,300
  • Consulting · 2020-06-05 · $1,625
CelgeneRevlimid$5,290
4 payments
  • Consulting · 2020-10-21 · $375
  • Consulting for Revlimid · 2020-07-01 · $2,625
  • Consulting · 2020-05-15 · $2,250
  • Meals · 2020-02-14 · $40
Janssen Scientific AffairsNone$5,270
1 payment
  • Consulting · 2020-08-19 · $5,270
GenzymeSarclisa$4,782
3 payments
  • Consulting for Sarclisa · 2020-09-14 · $1,370
  • Consulting · 2020-06-02 · $3,290
  • Meals for Elitek · 2020-02-26 · $122
Janssen BiotechDarzalex$4,658
5 payments
  • Paid to speak or teach for Darzalex · 2020-12-30 · $4,200
  • Travel for Darzalex · 2020-12-14 · $349
  • Meals for Darzalex · 2020-02-28 · $37
  • Meals for Darzalex · 2020-02-25 · $39
  • Meals for Darzalex · 2020-01-14 · $33
Janssen Research & DevelopmentEdurant$2,114
5 payments
  • Consulting · 2020-10-02 · $1,550
  • Meals for Edurant · 2020-01-30 · $78
  • Travel · 2020-01-22 · $259
  • Travel · 2020-01-22 · $114
  • Travel · 2020-01-22 · $114
Ethicon Endo-SurgeryNone$594
1 payment
  • Travel · 2020-03-31 · $594
AstraZeneca Pharmaceuticals LPTagrisso$125
1 payment
  • Meals for Tagrisso · 2020-02-05 · $125

2019: $186,366

Payments by company in 2019
Foundation MedicineFoundationact$112,125
17 payments
  • Consulting for Foundationone Liquid · 2019-12-27 · $14,344
  • Consulting for Foundationone Liquid · 2019-12-27 · $4,681
  • Consulting for Foundationact · 2019-07-11 · $4,826
  • Consulting for Foundationact · 2019-07-11 · $3,688
  • Consulting for Foundationact · 2019-07-11 · $7,819
  • Consulting for Foundationact · 2019-07-11 · $3,356
  • Consulting for Foundationact · 2019-05-23 · $4,078
  • Consulting for Foundationact · 2019-05-23 · $6,600
  • Consulting for Foundationact · 2019-04-25 · $7,214
  • Consulting for Foundationact · 2019-04-25 · $3,775
  • Consulting for Foundationact · 2019-04-25 · $7,639
  • Consulting for Foundationact · 2019-03-20 · $5,477
  • Consulting for Foundationact · 2019-03-20 · $6,764
  • Consulting for Foundationact · 2019-03-20 · $8,585
  • Consulting for Foundationact · 2019-03-20 · $5,176
  • Consulting for Foundationact · 2019-03-20 · $8,588
  • Consulting for Foundationact · 2019-03-20 · $9,514
Takeda Pharmaceuticals U.S.A.None$30,754
23 payments
  • Travel · 2019-12-05 · $547
  • Paid to speak or teach · 2019-11-26 · $2,750
  • Meals · 2019-11-26 · $116
  • Travel · 2019-11-20 · $390
  • Paid to speak or teach · 2019-11-14 · $2,750
  • Travel · 2019-10-18 · $504
  • Travel · 2019-10-15 · $568
  • Paid to speak or teach · 2019-10-04 · $2,750
  • Paid to speak or teach · 2019-09-27 · $2,750
  • Travel · 2019-08-21 · $511
  • Paid to speak or teach · 2019-08-14 · $2,750
  • Meals · 2019-08-14 · $32
  • Travel · 2019-07-05 · $427
  • Paid to speak or teach · 2019-05-03 · $3,850
  • Meals · 2019-05-03 · $135
  • Travel · 2019-03-25 · $526
  • Travel · 2019-03-15 · $425
  • Travel · 2019-03-11 · $577
  • Paid to speak or teach · 2019-03-11 · $2,750
  • Paid to speak or teach · 2019-02-26 · $2,750
  • Meals · 2019-02-26 · $22
  • Paid to speak or teach · 2019-02-19 · $2,750
  • Meals · 2019-02-19 · $125
CelgeneBb-2121$19,499
22 payments
  • Consulting for Revlimid · 2019-12-18 · $2,250
  • Meals for Revlimid · 2019-12-10 · $19
  • Meals for Revlimid · 2019-12-10 · $45
  • Meals for Revlimid · 2019-12-10 · $25
  • Meals for Bb-2121 · 2019-11-15 · $21
  • Meals for Bb-2121 · 2019-11-15 · $35
  • Consulting for Bb-2121 · 2019-11-15 · $6,375
  • Travel for Bb-2121 · 2019-11-14 · $228
  • Travel for Bb-2121 · 2019-11-14 · $327
  • Meals for Bb-2121 · 2019-11-14 · $125
  • Meals for Revlimid · 2019-11-12 · $15
  • Meals for Bb-2121 · 2019-10-18 · $60
  • Travel for Bb-2121 · 2019-10-18 · $94
  • Travel for Bb-2121 · 2019-10-18 · $290
  • Meals for Bb-2121 · 2019-10-18 · $40
  • Travel for Bb-2121 · 2019-10-18 · $150
  • Consulting for Bb-2121 · 2019-10-18 · $9,000
  • Travel for Bb-2121 · 2019-10-18 · $226
  • Meals for Bb-2121 · 2019-10-18 · $55
  • Meals for Pomalyst · 2019-09-14 · $26
  • Meals · 2019-04-26 · $65
  • Meals · 2019-02-08 · $27
Janssen Global ServicesPipeline$14,012
12 payments
  • Meals for Pipeline · 2019-12-06 · $21
  • Consulting · 2019-11-05 · $3,030
  • Consulting · 2019-10-17 · $5,600
  • Meals · 2019-10-17 · $38
  • Meals · 2019-10-17 · $57
  • Meals · 2019-10-17 · $28
  • Meals · 2019-10-17 · $32
  • Meals · 2019-10-16 · $125
  • Consulting · 2019-09-15 · $4,900
  • Meals · 2019-09-15 · $46
  • Meals · 2019-09-15 · $15
  • Meals · 2019-09-11 · $121
Janssen BiotechDarzalex$9,443
17 payments
  • Consulting · 2019-12-31 · $6,000
  • Travel · 2019-12-31 · $129
  • Meals · 2019-12-31 · $50
  • Travel for Darzalex · 2019-12-18 · $695
  • Meals for Darzalex · 2019-12-06 · $113
  • Meals for Darzalex · 2019-12-06 · $82
  • Travel · 2019-11-16 · $862
  • Meals · 2019-11-16 · $30
  • Meals · 2019-11-16 · $50
  • Meals · 2019-11-16 · $15
  • Meals for Darzalex · 2019-11-05 · $29
  • Consulting for Darzalex · 2019-10-15 · $990
  • Meals for Darzalex · 2019-10-08 · $24
  • Travel for Darzalex · 2019-10-04 · $163
  • Meals for Darzalex · 2019-10-04 · $123
  • Meals for Darzalex · 2019-09-14 · $73
  • Meals for Darzalex · 2019-09-14 · $14
E.R. Squibb & Sons L.L.C.None$307
3 payments
  • Travel · 2019-06-29 · $105
  • Travel · 2019-06-12 · $63
  • Travel · 2019-04-06 · $139
AmgenNone$125
1 payment
  • Meals · 2019-05-31 · $125
Secura BioFarydak$102
1 payment
  • Meals for Farydak · 2019-09-15 · $102

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Celgene Corporation · Ph Iib Ide-Cel Multi-Cohort Mono Rrmm · 2020Their institution$880,575
Celgene Corporation · Ph Iib Ide-Cel Multi-Cohort Mono Rrmm (Bb2121-Mm-002) · 2019Their institution$394,527
Celgene Corporation · Ph Iib Ide-Cel Multi-Cohort Mono Rrmm - A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Evaluate the Efficacy and Safety of Bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With Clinical High-Risk Multiple Myeloma · 2022Their institution$389,260
Amgen Inc. · Amg 701 Ph1/2 Non-Randomized Open-Label Expansion Mm · 2020Their institution$367,548
Amgen Inc. · Amg 701 Non-Randomized Open-Label Expansion Multiple Myeloma 20170122 · 2019Their institution$249,318
Janssen Research & Development, LLC · A Phase 2 Multicohort Open Label Study of Jnj68284528 A Chimeric Antigen Receptor T Cell Cart Therapy Directed Against Bcma in Subjects With Multiple Myeloma · 2021Their institution$202,343
Janssen Research & Development, LLC · A Phase 2, Multicohort Open-Label Study of Jnj-68284528, A Chimeric Antigen Receptor T Cell (Car-T) Therapy Directed Against Bcma in Subjects With Multiple Myeloma · 2020Their institution$195,204
Celgene Corporation · (Cc-99712-Mm-001) Ph I R/R Mm - A Phase 1, Multicenter, Open-Label, Dose Finding Study of Cc-99712, A Bcma Antibody-Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma · 2023Their institution$185,906
Celgene Corporation · (Cc-99712-Mm-001) Ph I R/R Mm Dose Escalation (Bms Study Number: Ca060-P01) · 2020Their institution$128,904
Celgene Corporation · A Phase 1, Multicenter, Open-Label, Dose Finding S · 2021Their institution$111,687
Celgene Corporation · A Phase 2, Multi-Cohort, Open-Label, Multicenter S · 2021Their institution$87,997
Celgene Corporation · A Phase I, Multi Center, Open Label Study of Cc-98633, Bcma Targeted Nex-T Chimeric Antigen Receptor (Car) T Cells, in Subjects With Relapsed and/Or Refractory Multiple Myeloma · 2020Their institution$65,988
Regeneron Pharmaceuticals, Inc. · Phase 1/2 Fih Study of Regn5459 (Anti-Bcma X Anti-Cd3 Bispecific Antibody) in Patients With Relapsed Or Refractory Multiple Myeloma · 2020Their institution$32,764
Amgen Inc. · Amg 701 P1/2 Non-Randomized Open-Label Expansion Mm · 2021Their institution$2,899
Celgene Corporation · Crb-401 A Phase 1 Study of Bb2121 in Bcma-Expressing Multiple Myeloma (Crb-401) · 2019This clinician$2,866
Amgen Inc. · Amg 701 P1/2 Non-Randomized Open-Label Expansion Mm · 2023Their institution$2,087
Regeneron Pharmaceuticals, Inc. · Phase 1/2 Fih Study of Regn5458 (Anti-Bcma X Anti-Cd3 Bispecific Antibody) in Patients With Relapsed Or Refractory Multiple Myeloma · 2020This clinician$1,022
Regeneron Pharmaceuticals, Inc. · Phase 1 2 Fih Study of Regn5458 Anti-Bcma X Anti-Cd3 Bispecific Antibody in Patients With Relapsed Or Refractory Multiple Myeloma · 2019This clinician$802
Regeneron Pharmaceuticals, Inc. · Phase 1/2 Fih Study of Regn5458 (Anti-Bcma X Anti-Cd3 Bispecific Antibody) in Patients With Relapsed Or Refractory Multiple Myeloma · 2021This clinician$708

Professional record

NPI
1740418318
Licence
CA A107001, NY 282643California A107001: Current · expires 2026-12-31
Trained
University of Oklahoma College of Medicine, 2007
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0000X (207RH0000X); Internal medicine (207R00000X); Medical oncology (207RX0202X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2009-06-23
NPI last updated
2024-04-12
NPI record certified
2024-04-12

This is when the NPI record was last certified, not a medical board exam.